Company Profile
CEO
Dr. Reshma Kewalramani FASN, M.D.(CEO, President & Director)
Sector
Healthcare
Industry
Biotechnology
Employees
6.4K
Beta
0.31
Forward P/E
20.8
52W High
$507.92
52W Low
$362.50
Profit Margin
35.5%
Operating Margin
38.1%
Return on Equity
24.2%
Revenue Growth
7.8%
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfus...
Valuation
Market Cap$112.43B
P/E (TTM)26.28
P/S (TTM)9.41
EV/EBITDA22.41
Cash Flow
FCF Yield+4.6%
SBC Adj. FCF Yield+4.0%
SBC Impact12.9%
Margins & Growth
Profit Margin34.5%
Operating Margin38.1%
Revenue YoY7.8%
Earnings YoY59.6%
Balance
Cash$5.50B
Debt$105.00M
Net Cash$5.40B
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--